닫기
검색

ScienceON 논문 검색

  • home
  • ScienceON 논문 검색
search

검색어 : 통합검색[Whitworth Laura]

99건 중 99건 출력

, 7/10 페이지

  • 61
    Abstract PD9-01: 5-year outcomes in the NBRST trial: Preoperative MammaPrint and BluePrint breast cancer subtype is associated with neoadjuvant treatment response and survival
    Whitworth, Pat; Pellicane Jr., James V; Baron, Paul; Beitsch, Peter; Lee, Laura; Rotkis, Michael; Mislowsky, Angela; Dul, Carrie; Nash, Charles; Nguyen, Bichlien; Murray, Mary; Richards, Paul; Gittleman, Mark; Akbari, Stephanie; Wang, Shiyu; Yoder, Erin B; Menicucci, Andrea; Blumencranz, Lisa; Audeh, William; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.81, 2021, pp.PD9-01-PD9-01)
  • 62
    Impact of Tumor Size on Probability of Pathologic Complete Response After Neoadjuvant Chemotherapy
    Baron, Paul; Beitsch, Peter; Boselli, Danielle; Symanowski, James; Pellicane, James V.; Beatty, Jennifer; Richards, Paul; Mislowsky, Angela; Nash, Charles; Lee, Laura A.; Murray, Mary; de Snoo, Femke A.; Stork-Sloots, Lisette; Gittleman, Mark; Akbari, Stephanie; Whitworth, Pat; Department of Surgery, Breast and Melanoma Specialists of Charleston, Charleston, SC USA; Department of Surgery, Dallas Surgical Group, Dallas, TX USA; Department of Biostatistics, Levine Cancer Institute, Charlotte, NC USA; Department of Biostatistics, Levine Cancer Institute, Charlotte, NC USA; Department of Surgery, Virginia Breast Center, Bon Secours Cancer Institute, Richmond, VA USA; Department of Surgery, The Breast Place, Charleston, SC USA; Department of Surgery, Blue Ridge Cancer Care, Roanoke, VA USA; Department of Surgery, Coastal Carolina Breast Center, Murrells Inlet, SC USA; Department of Surgery, Northeast Georgia Medical Center, Gainesville, GA USA; Department of Surgery, Comprehensive Cancer Center, Palm Springs, CA USA; Department of Surgery, Akron General Hospital, Akron, OH USA; Department of Medical Affairs, Agendia Inc, Irvine, CA USA; Department of Medical Affairs, Agendia Inc, Irvine, CA USA; Department of Surgery, Breast Care Specialists, Allentow; (Annals of surgical oncology, v.23, 2016, pp.1522-1529)
  • 63
    Abstract PS4-04: Molecular subtyping by BluePrint improves prediction of treatment responses and survival outcomes in patients with discordant clinical and genomic classification
    Whitworth, Pat; Pellicane Jr., James; Baron, Paul; Beitsch, Peter; Lee, Laura; Rotkis, Michael; Mislowsky, Angela; Dul, Carrie; Nash, Charles; Nguyen, Bichlien; Murray, Mary; Richards, Paul; Gittleman, Mark; Akbari, Stephanie; Wang, Shiyu; Menicucci, Andrea; Yoder, Erin B; Blumencranz, Lisa; Audeh, William; ; (Cancer research : the official organ of the American Association for Cancer Research, Inc, v.81, 2021, pp.PS4-04-PS4-04)
  • 64
    A phase I study to assess the safety, tolerability, and PK of dovitinib (D) in combination with gemcitabine (G) and capecitabine (C) in patients with advanced solid tumors.
    Fetterly, Gerald J.; Pitzonka, Laura; Zhao, Yujie; Dy, Grace K.; Iyer, Renuka V.; Taubes, Susan; Perez, Jose Ricardo; Culver, Kenneth W.; Wilton, John; Mongiardo, Krystin; Tan, Wei; Brady, William E.; Whitworth, Amy; Adjei, Alex A.; Ma, Wen Wee; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; Novartis Pharmaceuticals, East Hanover, NJ; Novartis Pharmaceuticals Corp, East Hanover, NJ; Novartis Pharmaceuticals Corporation, East Hanover, NJ; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; Roswell Park Cancer Institute, Buffalo, NY; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.32, 2014, pp.2603-2603)
  • 65
    Elevated cerebrospinal fluid cytokine levels in tuberculous meningitis predict survival in response to dexamethasone
    Whitworth, Laura J.; Troll, Rajan; Pagá n, Antonio J.; Roca, Francisco J.; Edelstein, Paul H.; Troll, Mark; Tobin, David M.; Phu, Nguyen Hoan; Bang, Nguyen Duc; Thwaites, Guy E.; Thuong, Nguyen Thuy Thuong; Sewell, Roger F.; Ramakrishnan, Lalita; Molecular Immunity Unit, Department of Medicine, University of Cambridge, CB2 0QH Cambridge, United Kingdom; ; Trinity College, CB2 1TQ Cambridge, United Kingdom; ; Molecular Immunity Unit, Department of Medicine, University of Cambridge, CB2 0QH Cambridge, United Kingdom; ; Molecular Immunity Unit, Department of Medicine, University of Cambridge, CB2 0QH Cambridge, United Kingdom; ; Molecular Immunity Unit, Department of Medicine, University of Cambridge, CB2 0QH Cambridge, United Kingdom; ; Molecular Immunity Unit, Department of Medicine, University of Cambridge, CB2 0QH Cambridge, United Kingdom; ; Department of Molecular Genetics and Microbiology, Duke University School of Medicine, Durham, NC 27710; ; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; ; Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease, Ho Chi Minh City, Vietnam; ; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam; ; Oxford University Clinical Research Unit, Ho Chi Minh; (Proceedings of the National Academy of Sciences of the United States of America, v.118, 2021, pp.e2024852118-e2024852118)
  • 66
    Book reviews
    Cowperthwaite Editor, L. LeRoy; Parrish, W. M.; Crowell, Laura; Whitworth, Oretha Jane; Pfendler, Robert C.; Ogilvie, Mardel; Albright, Robert W.; Hargis, Donald E.; Davee, Paul W.; Richardson, Genevieve; Williams, Alton; Mattingly, Alethea Smith; Garrison, Geraldine; Hegarty, Inez E.; Peebles, Mary Elizabeth; Dance, Francis E. X.; ; (The Speech teacher, v.5, 1956, pp.324-334)
  • 67
    Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD)
    Edwards, Christopher L; Raynor, Renee Dunn; Feliu, Miriam; McDougald, Camela; Johnson, Stephanie; Schmechel, Donald; Wood, Mary; Bennett, Gary G; Saurona, Patrick; Bonner, Melanie; Wellington, Chante’; DeCastro, Laura M; Whitworth, Elaine; Abrams, Mary; Logue, Patrick; Edwards, Lekisha; Martinez, Salutario; Whitfield, Keith E; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; ; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; ; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; ; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; ; American Psychological Association, Science Directorate, Washington, DC, USA; ; Department of Medicine, Division of Neurology, Duke University Medical Center, Durham, NC, USA; ; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, USA; ; Department of Society, Human Development, and Health, Harvard School of Public Health, Boston, MA, USA; ; Taub Institute For Research on Alzheimer’s Disease and The Aging Brain, Columbia University, New York, NY, USA; ; Department of Psychiatry and Behavioral Sciences, Duke University Medical Center, Durham, NC, U; (Neuropsychiatric disease and treatment, v.3, 2007, pp.705-709)
  • 68
    The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy
    Webster, Christopher P; Smith, Emma F; Bauer, Claudia S; Moller, Annekathrin; Hautbergue, Guillaume M; Ferraiuolo, Laura; Myszczynska, Monika A; Higginbottom, Adrian; Walsh, Matthew J; Whitworth, Alexander J; Kaspar, Brian K; Meyer, Kathrin; Shaw, Pamela J; Grierson, Andrew J; De Vos, Kurt J; Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, Sheffield, UK; Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, Sheffield, UK; Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, Sheffield, UK; Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, Sheffield, UK; Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, Sheffield, UK; Sheffield Institute for Translational Neuroscience (SITraN), Department of Neuroscience, University of Sheffield, Sheffield, UK xx; (The EMBO journal, v.35, 2016, pp.1656-1676)
  • 69
    Determining whether functional subtyping with BluePrint 80-gene profile could potentially identify two distinct triple positive subtypes with and without trastuzumab/chemo-sensitivity.
    Whitworth, Pat W.; Beitsch, Peter D.; Rotkis, Michael C.; Pellicane, James V.; Murray, Mary; Baron, Paul; Dul, Carrie L.; Mislowsky, Angela Marie; Nash, Charles H.; Richards, Paul D.; Lee, Laura A.; Stork, Lisette; De Snoo, Femke; Untch, Sarah; Gittleman, Mark; Akbari, Stephanie; Beatty, Jennifer; NRG Oncology/NSABP, ALLIANCE/ACOSOG, and Nashville Breast Center, Nashville, TN; Dallas Surgcl Grp, Dallas, TX; Northern Indiana Cancer Research Consortium, South Bend, IN; Virginia Breast Center, Bon Secours Cancer Institute, Richmond, VA; Akron General Medical Center, Akron, OH; Cancer Specialists of Charleston, Charleston, SC; Great Lakes Management Spclsts, Grosse Pointe Park, MI; Coastal Carolina Breast Center, Murrells Inlet, SC; The Longstreet Clinic PC, Gainesville, GA; Onc and Hem Assoc of Southwest VA, Salem, VA; Comprehensive Cancer Center, Palm Springs, CA; Agendia, Amsterdam, Netherlands; Agendia, Amsterdam, Netherlands; Agendia, Irvine, CA; Breast Care Specialists, Allentown, PA; Virginia Hospital Center Reinsch Pierce Family Center for Breast Health, Arlington, VA; The Breast Place, Charleston, SC; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.596-596)
  • 70
    Functional subtyping with BluePrint 80-gene profile to identify distinct triple-positive subtypes with and without trastuzumab/chemosensitivity.
    Whitworth, Pat W.; Beitsch, Peter D.; Rotkis, Michael C.; Pellicane, James V.; Murray, Mary; Baron, Paul; Dul, Carrie L.; Mislowsky, Angela Marie; Nash, Charles H.; Richards, Paul D.; Lee, Laura A.; Stork, Lisette; De Snoo, Femke; Untch, Sarah; Gittleman, Mark; Akbari, Stephanie; Beatty, Jennifer; NRG Oncology/NSABP, ALLIANCE/ACOSOG, and Nashville Breast Center, Nashville, TN; Dallas Surgical Group, Dallas, TX; Northern Indiana Cancer Research Consortium, South Bend, IN; Virginia Breast Center, Bon Secours Cancer Institute, Richmond, VA; Akron General Medical Center, Akron, OH; Cancer Specialists of Charleston, Charleston, SC; Great Lakes Management Spclsts, Grosse Pointe Park, MI; Coastal Carolina Breast Center, Murrells Inlet, SC; The Longstreet Clinic PC, Gainesville, GA; Oncology and Hematology Association of Southwest Virginia, Salem, VA; Comprehensive Cancer Center, Palm Springs, CA; Agendia, Amsterdam, Netherlands; Agendia, Amsterdam, Netherlands; Agendia, Irvine, CA; Breast Care Specialists, Allentown, PA; Virginia Hospital Center Reinsch Pierce Family Center for Breast Health, Arlington, VA; The Breast Place, Charleston, SC; (Journal of clinical oncology : official journal of the American Society of Clinical Oncology, v.33, 2015, pp.114-114)

처음 오셨나요?